| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $34.4M | -20.0% | +2.6% |
| SG&A Expense | $13.2M | +8.6% | +76.8% |
| Operating Income | -$52.6M | +4.7% | -28.3% |
| Pre-tax Income | -$51.5M | +1.3% | -33.4% |
| Income Tax | -$185K | -1025.0% | — |
| Net Income | -$51.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $115.6M | +162.6% | -67.9% |
| Short-term Investments | $175.3M | -23.5% | +555.1% |
| Current Assets | $296.6M | +6.5% | -24.7% |
| Total Assets | $322.0M | +9.9% | -20.2% |
| Current Liabilities | $52.4M | -1.5% | +19.1% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$119.9M | — | — |
| Capital Expenditures | $18K | — | — |
| Investing Cash Flow | -$158.5M | — | — |
| Financing Cash Flow | $74.4M | — | — |
| Free Cash Flow | -$119.9M | — | — |
| -33.4% |
| EPS (Basic) | -$1.22 | +2.4% | +75.7% |
| EPS (Diluted) | -$1.22 | +2.4% | +75.7% |
| $73.0M |
| — |
| — |
| Total Liabilities | $125.6M | +134.9% | +185.5% |
| Stockholders' Equity | $196.4M | -18.0% | -45.4% |